Infection

Chapter 10. Infection
Congenital infections with organisms that may have little effect on an adult or older child can have a devastating effect on the fetus and infant, resulting in profound long-term damage. The commonest cause of congenital infection is cytomegalovirus affecting 0.5–3% of live births worldwide. In very low birth weight infants who need prolonged intensive care, rates of culture-proven infection of up to 30% have been quoted, with mortality rates that are equally high. Neonatal units are busy and as they become busier both time and staffing constraints lead to an increase in nosocomial infections.
Questions in this chapter will cover different aspects of congenital infections, the presentation of sepsis, prevention of infection and other common situations such as contact with chickenpox on the neonatal unit.

QUESTION 1

Which of the following statements about cytomegalovirus (CMV) are correct (answer true or false)?
i) CMV is an RNA virus
ii) It is the most common intra-uterine infection
iii) Congenital CMV can be caused by maternal primary infection or reactivation and both are of the same severity
iv) The incidence of primary CMV infection acquired during pregnancy is 5–10%
v) Primary CMV infection is associated with a 40% risk of congenital CMV infection
vi) At least 50% of infected infants will show clinical signs at birth
vii) There is a 20% mortality associated with symptomatic congenital CMV
viii) Infants can become infected by breast feeding if the mother is seropositive.

QUESTION 4

The following features are typically associated with which intrauterine infection – hydrocephalus, epilepsy, cerebral calcification and chorioretinitis. Choose the best answer.
i) Congenital CMV
ii) Congenital toxoplasmosis
iii) Congenital Epstein–Barr virus
iv) Congenital varicella
v) Congenital rubella
vi) Congenital herpes
vii) Congenital TB.

QUESTION 5

Which of the following statements are true of toxoplasmosis?
i) The risk of congenital infection remains constant throughout pregnancy
ii) The risk of congenital infection is up to 90% in the third trimester
iii) Congenital infection is more severe if maternal infection is acquired in the third trimester
iv) In the UK, about 60% of women are sero-positive
v) Congenital infection occurs in 1 in 100 exposed babies
vi) Increasing gestational age at seroconversion is associated with an increased risk of mother-to-child transmission
vii) CSF will show a lymphocytosis
viii) Toxoplasmosis cannot be treated
ix) If diagnosed antenatally in the first trimester the mother can be treated with pyrimethamine and sulfadiazine to decrease the risk of fetal infection
x) If there are no eye signs within the first year of birth, the infant is unlikely to develop ocular problems.

QUESTION 6

You are called to the postnatal ward to review a baby who is 8 hours old.
The results of the initial investigations are obtained and shown below:
Hb 14.7 g/dL
WBC 21.4×10 9/L
Neut 1.7×10 9/L
Platelets 104 × 10 9/L
CRP 94 mg/L
Urine SPA sample – no cells, no organisms seen
Chest x-ray shows a diffuse, fine, reticulogranular pattern, much like that seen in RDS.
The infant is breathing without ventilatory support with some low flow oxygen to maintain his saturations. He has had his first dose of antibiotics and is currently on maintenance fluid.
vi) What do you do now?
A lumbar puncture is carried out and the result is below:
RBC 18,000/mm 3
WCC 12/mm 3
Protein 2.5 g/L
Glucose 1.4 mmol/L
CSF is moderately blood stained
vii) What does this result mean?
There is a phone call from the microbiology department the following day saying the blood cultures are growing Group B Streptococcus. The infant’s CRP is now 40 mg/L, and his platelets have been stable above 100 after the platelet transfusion.
ix)
a. How will you modify your treatment, if at all?
b. How long will you treat the baby?
c. What will you tell the parents?

QUESTION 7

A baby is born at term by normal vaginal delivery with good Apgars requiring no resuscitation. Membranes were ruptured just prior to delivery, and the mother was well throughout pregnancy and labour. The mother is a primigravida. You receive a phone call from the midwife looking after the mother, when the baby is 12 hours old to say group B Streptococcus is growing from a maternal high vaginal swab. The mother wishes to go home.
What do you do? Choose the best answer.
i) Admit the baby to the NICU for observation
ii) Admit the baby to the NICU for observation and routine surface swabs
iii) Admit the baby to the NICU for a septic screen (blood cultures, FBC and CRP) and await results before considering antibiotics
iv) Admit the baby to NICU, perform septic screen and start antibiotics
v) Reassure and discharge home
vi) Allow to go home with instructions if the baby becomes unwell to seek medical advice
vii) Discuss with the mother and say that she must stay in and the baby must be observed for a further 24 hours
viii) Observe the baby for another 12 hours; allow to go home with instructions if the baby becomes unwell to seek medical advice.

QUESTION 9

Which of the following organisms are known to commonly cause osteomyelitis? Choose four answers.
i) Bacillus fragilis
ii) Bacillus cereus
iii) Bacteroides fragilis
iv) Campylobacter jejuni
v) Haemophilus influenzae
vi) Proteus mirabilis
vii) Salmonella typhi
viii) Group B streptococcus (GBS)
ix) Staphylococcus aureus
x) Klebsiella
xi) Serratia marcescens.

QUESTION 10

Which of the following babies should receive hepatitis B immunoglobulin?
i) Mother is HBsAg negative and HBeAg negative
ii) Mother is HBsAg negative and HBeAg positive
iii) Mother is HBsAg positive and HBeAg negative
iv) Mother is HBsAg positive and HBeAg positive
v) Mother had acute hepatitis during pregnancy
vi) Mother where eAg and eAb status are unknown.

QUESTION 13

You are called to see a baby after delivery. The mother has had routine booking bloods and serology. The results are as follows:
RPR reactive
TPHA reactive
Rubella immune
Hepatitis negative
i) What do these test show?
ii) What test do you carry out to confirm this?
The confirmatory test is also reactive.
iii) What do you do now? Name two things.
iv) Which one test would confirm a diagnosis of congenital syphilis?
v) If the test is negative, what does this show?
vi) What information do you need from the mother?
vii) What other test might be helpful in assessing the risk to the baby?
On examination the baby looks normal, the non-treponemal serologic titre is less than four times the maternal titre, and the mother had treatment 2 weeks ago.
viii) What do you do?

QUESTION 14

On your neonatal unit, three babies are found to be growing an Enterobacter with identical antibiotic resistance. It is the opinion of the microbiologists that these must have been transmitted by staff contact. It is their recommendation that the three infants are isolated and barrier nursed and that there is a serious review of infection control procedures.

ANSWER 1

i) False – CMV is a DNA virus of the herpes virus group.
ii) True – it affects up to 2.5% of live born infants a year worldwide. In the UK the incidence is approximately 0.2%.
iv) False – the incidence is thought to be 1–4%.
v) True.2
vi) False – overall, only 10–15% of infected infants show clinical signs at birth but up to 90% of these will develop long-term sequelae. 3
vii) True – reports state mortality ranges between 10% and 30% although much higher in premature infants.
viii) True – in the postpartum period, mother to infant transmission can occur as up to 88% of seropositive mothers shed the virus into their milk. Approximately 50% of these infants will become infected. CMV excretion is usually the result of reactivation in a seropositive mother; most infants will not develop clinical signs due to the presence of maternally derived transplacental antibodies. This is usually a benign and asymptomatic infection.

ANSWER 2

i) Echogenic bowel, intracranial calcification, cortical dysplasia.
ii) Answers a, b, c, e, g and h are correct. Hepatosplenomegaly and petechiae secondary to thrombocytopenia are relatively common manifestations of congenital CMV in the neonatal period. Jaundice is also common but this is usually a conjugated hyperbilirubinaemia as CMV hepatitis can cause both intrahepatic and extrahepatic bile duct destruction. 4 Intracranial manifestations of congenital CMV are microcephaly and periventricular calcification where the infection has caused brain necrosis. Lissencephaly and polymicrogyria can be present depending on the timing of the infection, lissencephaly occurring with an earlier infection. Defective enamelisation occurs in 40% of symptomatic infants at birth and 5% of asymptomatic infants. Inguinal hernias can occur with congenital CMV in male infants although the reason for this is unclear.
iii) Up to 80% of symptomatic newborns will develop sequelae such as mental retardation, cerebral palsy, visual defects and sensorineural hearing loss. Symptoms at birth are associated with a worse prognosis. 5
iv) Up to 15% of infants who are asymptomatic at birth will have neurodevelopmental problems and sensorineural (SN) deafness. SN deafness is the most common abnormality seen in congenital CMV infection, occurring in 30–65% of symptomatic infants and up to 15% of asymptomatic infants. It usually develops after the newborn period and tends to be progressive. Cochlear implants have been used successfully.
v) Answer c is correct.
a. Detection of the pp65 antigen has been used to detect active infection in immunocompromised people but due to the large quantity of blood required this test is less useful in neonates. However a recent paper showed that high levels of pp65 antigen in the blood were seen in newborns that developed sequelae. 5 This test is very rarely used in the UK as it has been superseded by PCR.
b. High viral load in the urine is highly predictive of audiological impairment. 6
c. PCR is the gold standard for testing for congenital CMV.
d. A positive IgG reflects passage of maternal antibodies and therefore does not diagnose infection in the baby. Maternal IgG can persist up to 12 months. A positive IgM test does suggest congenital infection but both false positive and false negative results can occur. The test has a sensitivity of approximately 75%. With the availability of PCR, viral serology should not be used to diagnose congenital infection.
e. Skin biopsy – this is not used for CMV testing.
vi) PCR testing on a urine sample needs to be done within the first 3 weeks after birth. If the test is carried out after 3 weeks it is difficult to distinguish between a congenital, perinatal or postnatal infection. Infants infected at birth after exposure to infected secretions during delivery may start shedding virus by 3 weeks of age.
vii) There are currently a few antiviral chemotherapeutic agents, such as ganciclovir and foscarnet, that are available for treatment of serious, life-threatening or sight-threatening CMV in the immunocompromised patients. Cidofovir is also licensed for CMV retinitis. A randomised, controlled multicentre clinical trial investigated the use of ganciclovir for the treatment of infants with congenital CMV infection with evidence of CNS involvement. 7 Ganciclovir (or placebo) was given intravenously as an infusion every 12 hours for 6 weeks. The ganciclovir group were significantly more likely to have improved or normal hearing at 6 months of age compared to the placebo group. They also showed improvement in their liver function tests and head circumference. No change in mortality was demonstrated and currently there are no published data on long-term outcome. Ganciclovir is not thought to be beneficial for infants who show severe intracranial pathology antenatally. Several centres in the UK are using a six-week course of intravenous ganciclovir and then switching over to oral valganciclovir, with close monitoring of levels and viral load to assess response. The main side effects of ganciclovir are secondary to bone marrow suppression. Nigro8 described a study using CMV specific hyperimmune globulin and found that pregnant women whose amniotic fluid was CMV positive, and who were given passive immunisation, had a lower rate of congenital CMV when compared to a control group. There are currently no randomised trials looking at this preventative treatment.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 11, 2016 | Posted by in PEDIATRICS | Comments Off on Infection

Full access? Get Clinical Tree

Get Clinical Tree app for offline access